Skip to content

Prepaid expenses at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
WisdomTree logo
WisdomTreeWT

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s prepaid expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s prepaid expenses?
BioSig Technologies, Inc. (STEX) reported prepaid expenses of $15.22M in Q1 2026.
How has BioSig Technologies, Inc.'s prepaid expenses changed year-over-year?
BioSig Technologies, Inc.'s prepaid expenses increased by 10046.7% year-over-year, from $150K to $15.22M.
What is the long-term trend for BioSig Technologies, Inc.'s prepaid expenses?
Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s prepaid expenses has grown at a 125.0% compound annual growth rate (CAGR), from $301K to $17.34M.